{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:48:03Z","timestamp":1771656483923,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T00:00:00Z","timestamp":1601683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T00:00:00Z","timestamp":1601683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00404-020-05822-w","type":"journal-article","created":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T17:02:56Z","timestamp":1601744576000},"page":"767-775","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Preoperative low hematocrit is an adverse prognostic biomarker in ovarian cancer"],"prefix":"10.1007","volume":"303","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0288-6549","authenticated-orcid":false,"given":"Junchen","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4203-0227","authenticated-orcid":false,"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9110-386X","authenticated-orcid":false,"given":"Heng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,3]]},"reference":[{"issue":"2","key":"5822_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ygyno.2018.11.034","volume":"152","author":"D Nie","year":"2019","unstructured":"Nie D, Gong H, Mao X, Li Z (2019) Systemic immune-inflammation index predicts prognosis in patients with epithelial ovarian cancer: a retrospective study. Gynecol Oncol 152(2):259\u2013264. https:\/\/doi.org\/10.1016\/j.ygyno.2018.11.034","journal-title":"Gynecol Oncol"},{"issue":"4","key":"5822_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21456","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A, Siegel RL (2018) Ovarian cancer statistics, 2018. CA Cancer J Clin 68(4):284\u2013296. https:\/\/doi.org\/10.3322\/caac.21456","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"5822_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/s1470-2045(18)30005-6","volume":"19","author":"G Scambia","year":"2018","unstructured":"Scambia G, Ferrandina G (2018) A turning point in the fight against ovarian cancer? Lancet Oncol 19(2):154\u2013156. https:\/\/doi.org\/10.1016\/s1470-2045(18)30005-6","journal-title":"Lancet Oncol"},{"key":"5822_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/1475-2875-6-166","volume":"6","author":"AJ Rodriguez-Morales","year":"2007","unstructured":"Rodriguez-Morales AJ, Sanchez E, Arria M, Vargas M, Piccolo C, Colina R, Franco-Paredes C (2007) Haemoglobin and haematocrit: the threefold conversion is also non valid for assessing anaemia in Plasmodium vivax malaria-endemic settings. Malar J 6:166. https:\/\/doi.org\/10.1186\/1475-2875-6-166","journal-title":"Malar J"},{"key":"5822_CR5","doi-asserted-by":"publisher","first-page":"6804938","DOI":"10.1155\/2018\/6804938","volume":"2018","author":"X Zhang","year":"2018","unstructured":"Zhang X, Zhang F, Qiao W, Zhang X, Zhao Z, Li M (2018) Low Hematocrit is a strong predictor of poor prognosis in lung cancer patients. Biomed Res Int 2018:6804938. https:\/\/doi.org\/10.1155\/2018\/6804938","journal-title":"Biomed Res Int"},{"issue":"9","key":"5822_CR6","first-page":"883","volume":"64","author":"CJO Seda","year":"2011","unstructured":"Seda CJO, Salas ASJ, S\u00e1nchez CG, Blasco JML, Garc\u00eda IO, S\u00e1nchez JMC, Ru\u00edz CBC, Navarro SM, L\u00f3pez RAM (2011) Thrombocytosis and hematocrit as prognostic factors in renal carcinoma. Arch Esp Urol 64(9):883\u2013890","journal-title":"Arch Esp Urol"},{"issue":"11","key":"5822_CR7","doi-asserted-by":"publisher","first-page":"e0165133","DOI":"10.1371\/journal.pone.0165133","volume":"11","author":"B Chen","year":"2016","unstructured":"Chen B, Dai D, Tang H, Ai X, Chen X, Zhang X, Li Z, Xie X (2016) Pretreatment hematocrit is superior to hemoglobin as a prognostic factor for triple negative breast cancer. PLoS ONE 11(11):e0165133. https:\/\/doi.org\/10.1371\/journal.pone.0165133","journal-title":"PLoS ONE"},{"issue":"1","key":"5822_CR8","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1186\/s12885-018-4970-9","volume":"18","author":"N Arora","year":"2018","unstructured":"Arora N, Talhouk A, McAlpine JN, Law MR, Hanley GE (2018) Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia. Canada BMC Cancer 18(1):1039. https:\/\/doi.org\/10.1186\/s12885-018-4970-9","journal-title":"Canada BMC Cancer"},{"issue":"6","key":"5822_CR9","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1182\/blood.V57.6.1065.1065","volume":"57","author":"JA Strauchen","year":"1981","unstructured":"Strauchen JA, Alston W, Anderson J, Gustafson Z, Fajardo LF (1981) Inaccuracy in automated measurement of hematocrit and corpuscular indices in the presence of severe hyperglycemia. Blood 57(6):1065\u20131067","journal-title":"Blood"},{"issue":"1","key":"5822_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ygyno.2019.07.025","volume":"155","author":"AS Zamorano","year":"2019","unstructured":"Zamorano AS, Hagemann AR, Morrison L, Lee JA, Liao LM, Brinton LA, Park Y, Toriola AT (2019) Pre-diagnosis body mass index, physical activity and ovarian cancer mortality. Gynecol Oncol 155(1):105\u2013111. https:\/\/doi.org\/10.1016\/j.ygyno.2019.07.025","journal-title":"Gynecol Oncol"},{"issue":"3","key":"5822_CR11","doi-asserted-by":"publisher","first-page":"e0194993","DOI":"10.1371\/journal.pone.0194993","volume":"13","author":"L-C Chang","year":"2018","unstructured":"Chang L-C, Huang C-F, Lai M-S, Shen L-J, Wu F-LL, Cheng W-F (2018) Prognostic factors in epithelial ovarian cancer: a population-based study. PLoS ONE 13(3):e0194993. https:\/\/doi.org\/10.1371\/journal.pone.0194993","journal-title":"PLoS ONE"},{"key":"5822_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bpobgyn.2016.10.009","volume":"41","author":"J Sehouli","year":"2017","unstructured":"Sehouli J, Grabowski JP (2017) Surgery for recurrent ovarian cancer: options and limits. Best Pract Res Clin Obstet Gynaecol 41:88\u201395. https:\/\/doi.org\/10.1016\/j.bpobgyn.2016.10.009","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"6","key":"5822_CR13","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/jso.21652","volume":"102","author":"J Sehouli","year":"2010","unstructured":"Sehouli J, Richter R, Braicu EI, Buhling KJ, Bahra M, Neuhaus P, Lichtenegger W, Fotopoulou C (2010) Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients. J Surg Oncol 102(6):656\u2013662. https:\/\/doi.org\/10.1002\/jso.21652","journal-title":"J Surg Oncol"},{"issue":"6","key":"5822_CR14","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1158\/1078-0432.CCR-06-2482","volume":"13","author":"J Dorn","year":"2007","unstructured":"Dorn J, Schmitt M, Kates R, Schmalfeldt B, Kiechle M, Scorilas A, Diamandis EP, Harbeck N (2007) Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients. Clin Cancer Res 13(6):1742\u20131748. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-2482","journal-title":"Clin Cancer Res"},{"issue":"1","key":"5822_CR15","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1186\/s12885-018-5162-3","volume":"18","author":"S Akhavan","year":"2018","unstructured":"Akhavan S, Ghahghaei-Nezamabadi A, Modaresgilani M, Mousavi AS, Sepidarkish M, Tehranian A, Rezayof E (2018) Impact of diabetes mellitus on epithelial ovarian cancer survival. BMC cancer 18(1):1246. https:\/\/doi.org\/10.1186\/s12885-018-5162-3","journal-title":"BMC cancer"},{"issue":"1","key":"5822_CR16","doi-asserted-by":"publisher","first-page":"9548","DOI":"10.1038\/s41598-017-10328-8","volume":"7","author":"W Zhang","year":"2017","unstructured":"Zhang W, Ye B, Liang W, Ren Y (2017) Preoperative prognostic nutritional index is a powerful predictor of prognosis in patients with stage III ovarian cancer. Sci Rep 7(1):9548. https:\/\/doi.org\/10.1038\/s41598-017-10328-8","journal-title":"Sci Rep"},{"issue":"1","key":"5822_CR17","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.3802\/jgo.2019.30.e5","volume":"30","author":"Q Ye","year":"2019","unstructured":"Ye Q, Cheng J, Ye M, Liu D, Zhang Y (2019) Association of pretreatment thrombocytosis with prognosis in ovarian cancer: a systematic review and meta-analysis. J Gynecol Oncol 30(1):e5. https:\/\/doi.org\/10.3802\/jgo.2019.30.e5","journal-title":"J Gynecol Oncol"},{"issue":"Suppl 7","key":"5822_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/annonc\/mdq284","volume":"21","author":"M Dicato","year":"2010","unstructured":"Dicato M, Plawny L, Diederich M (2010) Anemia in cancer. Ann Oncol 21(Suppl 7):167\u2013172. https:\/\/doi.org\/10.1093\/annonc\/mdq284","journal-title":"Ann Oncol"},{"issue":"4","key":"5822_CR19","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<726::AID-CNCR14>3.0.CO;2-U","volume":"83","author":"A Obermair","year":"1998","unstructured":"Obermair A, Handisurya A, Kaider A, Sevelda P, K\u00f6lbl H, Gitsch G (1998) The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients: a prospective review. Cancer 83(4):726\u2013731","journal-title":"Cancer"},{"issue":"8","key":"5822_CR20","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1634\/theoncologist.2010-0236","volume":"16","author":"JH Kim","year":"2011","unstructured":"Kim JH, Lee JM, Ryu KS, Lee YS, Park YG, Hur SY, Lee KH, Lee SH (2011) The prognostic impact of duration of anemia during chemotherapy in advanced epithelial ovarian cancer. Oncologist 16(8):1154\u20131161. https:\/\/doi.org\/10.1634\/theoncologist.2010-0236","journal-title":"Oncologist"},{"issue":"3","key":"5822_CR21","first-page":"837","volume":"23","author":"K M\u00fcnstedt","year":"2003","unstructured":"M\u00fcnstedt K, Kovacic M, Zygmunt M, Von Georgi R (2003) Impact of hemoglobin levels before and during chemotherapy on survival of patients with ovarian cancer. Int J Oncol 23(3):837\u2013843","journal-title":"Int J Oncol"},{"key":"5822_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010095","author":"Y Wang","year":"2018","unstructured":"Wang Y, Yu L, Ding J, Chen Y (2018) Iron metabolism in cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20010095","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5822_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.clim.2006.06.006","volume":"121","author":"TR Daniels","year":"2006","unstructured":"Daniels TR, Delgado T, Helguera G, Penichet ML (2006) The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. Clin Immunol 121(2):159\u2013176","journal-title":"Clin Immunol"},{"key":"5822_CR24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.freeradbiomed.2018.07.015","volume":"133","author":"S Recalcati","year":"2019","unstructured":"Recalcati S, Gammella E, Cairo G (2019) Dysregulation of iron metabolism in cancer stem cells. Free Radic Biol Med 133:216\u2013220. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.07.015","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"5822_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/abbs\/gmv063","volume":"47","author":"W Guo","year":"2015","unstructured":"Guo W, Zhang S, Chen Y, Zhang D, Yuan L, Cong H, Liu S (2015) An important role of the hepcidin-ferroportin signaling in affecting tumor growth and metastasis. Acta Biochim Biophys Sin (Shanghai) 47(9):703\u2013715. https:\/\/doi.org\/10.1093\/abbs\/gmv063","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"4\u20135","key":"5822_CR26","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.semcdb.2005.03.007","volume":"16","author":"H Axelson","year":"2005","unstructured":"Axelson H, Fredlund E, Ovenberger M, Landberg G, Pahlman S (2005) Hypoxia-induced dedifferentiation of tumor cells\u2013a mechanism behind heterogeneity and aggressiveness of solid tumors. Semin Cell Dev Biol 16(4\u20135):554\u2013563. https:\/\/doi.org\/10.1016\/j.semcdb.2005.03.007","journal-title":"Semin Cell Dev Biol"},{"issue":"28","key":"5822_CR27","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1038\/s41388-018-0189-0","volume":"37","author":"KDP Dorayappan","year":"2018","unstructured":"Dorayappan KDP, Wanner R, Wallbillich JJ, Saini U, Zingarelli R, Suarez AA, Cohn DE, Selvendiran K (2018) Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3\/Rab proteins. Oncogene 37(28):3806\u20133821. https:\/\/doi.org\/10.1038\/s41388-018-0189-0","journal-title":"Oncogene"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05822-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-020-05822-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05822-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T20:29:29Z","timestamp":1633379369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-020-05822-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["5822"],"URL":"https:\/\/doi.org\/10.1007\/s00404-020-05822-w","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,3]]},"assertion":[{"value":"18 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The retrospective study was approved by the Institutional Review Board of the Peking University People\u2019s Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was waived because of the retrospective nature of this study, which was approved by the Institutional Review Board of the Peking University People\u2019s Hospital.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}